CIK 0001477449
- Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043705970
- Phone
- +1 203-635-2002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- 4 Exercise or conversion Chief Operating Officer acquired 7,230 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 7,230 shares (option exercise)
- 4 Open-market sale Chief Executive Officer sold 42,674 shares at an average $223.76 ($9,548,561)
- 4 Open-market sale Director sold 164,931 shares at $226.06 ($37,283,906)
- 4 Open-market sale Chief Human Resources Officer sold 3,902 shares at $222.26 ($867,266)
- 4 Exercise or conversion Director acquired 7,173 shares (option exercise)
- 4 Exercise or conversion Director acquired 7,173 shares (option exercise)
- 4 Exercise or conversion Director acquired 713 shares (option exercise)
- 4 Exercise or conversion Director acquired 734 shares (option exercise)
- 4 Open-market sale Chief Human Resources Officer sold 1,750 shares at $298.26 ($521,955)
- 4 Open-market sale SVP Corporate Strategy sold 3,000 shares at $290.49 ($871,470)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale Chief Legal Officer, Secretary sold 2,610 shares at $269.85 ($704,309)
- 4 Open-market sale Chief Executive Officer sold 30,000 shares at $271.06 ($8,131,800)
- 4 Open-market sale Director sold 164,931 shares at $262.61 ($43,312,530)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Marketing Officer sold 7,000 shares at $265.02 ($1,855,140)
- 4 Open-market sale Head of Research & Development sold 8,261 shares at $280.00 ($2,313,080)
Page 23 of 47 · 921 filings